Leukemia
Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 study.
Ayumi Fujimoto, Takeshi Maeda, Noriko Doki, Noriko Fukuhara, Noriko Iwaki, Nobuhiro Hiramoto, Hideki Goto, Takuya Miyazaki, Ikue Shiki, Kana Miyazaki, Motoko Yamaguchi, Fumihiro Ishida, Ritsuro Suzuki
Published: 202610.1038/s41375-025-02854-6
Abstract
Aggressive NK-cell leukemia (ANKL) is a rare NK-cell leukemia characterized by, an aggressive clinical course, and frequent Epstein-Barr virus association. We retrospectively collected 126 ANKL patients diagnosed between 2000 and 2021 from 71 institu…
Preview only. Read the full abstract at the source